Oorsprong van het eerstegraads netwerk van Dario Alessi
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Ubiquigent Ltd.
Ubiquigent Ltd. Miscellaneous Commercial ServicesCommercial Services Ubiquigent Ltd. develops reagents, kits, drug discovery assay development and compound profiling services to the academic and commercial life science research community worldwide. It focus; namely the ubiquitin, ubiquitin-like and integrated signalling systems. The company has established its scientific and business credentials with both academic researchers undertaking fundamental scientific discovery as well as with pharmaceutical and biotechnology company scientists undertaking ubiquitin system-focused drug discovery. Ubiquigent was founded by Jason Brown in 2009 and is headquartered in Dundee, the United Kingdom.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Dario Alessi via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
QIAGEN Beverly LLC
QIAGEN Beverly LLC BiotechnologyHealth Technology Qiagen Beverly, Inc. produces reagents, kits and assays enables customers worldwide to transform patient treatment and life science research. Its products include xmal, mapl, taqiT, wgs ligase, sall, xhol and bamhi. The company was founded by Christopher Benoit and Stephen Picone in 2006 and is headquartered in Beverly, M A. | Biotechnology | Chairman | |
Global Cell Solutions, Inc.
Global Cell Solutions, Inc. Pharmaceuticals: OtherHealth Technology Global Cell Solutions, Inc. provides three-dimensional cell culturing tools and cell-based assays to researchers engaged in the fields of biotechnology, drug discovery, therapeutic, and pharmaceutical researches. The company was founded by Robin A. Felder and Uday Gupta in 2004 and is headquartered in North Garden, VA. | Pharmaceuticals: Other | Director/Board Member | |
Agilis Biotherapeutics LLC
Agilis Biotherapeutics LLC BiotechnologyHealth Technology Agilis Biotherapeutics LLC operates as a biotechnology company. It focuses on designing and engineering first-in-class DNA-based therapeutics to improve and save the lives of patients affected by life-threatening or fatal rare diseases for which there are no or limited treatment options. The company was founded in 2013 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
University of Virginia | College/University | Masters Business Admin | |
University of Bath | College/University | Masters Business Admin | |
Xention Pharma Ltd.
Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | Pharmaceuticals: Major | Founder | |
University of Cambridge | College/University | Doctorate Degree | |
Cambridge Drug Discovery Holdings Ltd.
Cambridge Drug Discovery Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., Cambridge Drug Discovery Holdings Ltd. is a company that researches potential new drugs for the treatment of cancer. The company is based in Cambridge, UK. Cambridge Drug Discovery Holdings was acquired by Charles River Discovery Research Services UK Ltd., part of Charles River Laboratories International, Inc. from November 14, 2005 on June 11, 2001 for $38 million. The British company was founded by Barry Kenny, Jonathan Mark Treherne. | Miscellaneous Commercial Services | Chief Executive Officer | |
Upstate Group LLC
Upstate Group LLC Pharmaceuticals: MajorHealth Technology Upstate Group LLC develops cell signaling products, technology platforms and services. It provides researchers at pharmaceutical and biotechnology companies, universities and government agencies with advanced tools to accelerate life science research and drug discovery. Upstate Group is a subsidiary of Serologicals Corp. The company was founded in 1988 and is headquartered in Charlottesville, VA. | Pharmaceuticals: Major | President | |
The University of Reading | College/University | Undergraduate Degree | |
University of Kentucky | College/University | Corporate Officer/Principal | |
University of Aarhus | College/University | Masters Business Admin | |
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Biotechnology | Director/Board Member | |
University of St. Andrews | College/University | Undergraduate Degree | |
NeuroSolutions Ltd.
NeuroSolutions Ltd. Miscellaneous Commercial ServicesCommercial Services NeuroSolutions Ltd. provides flexible and skilled services to biopharmaceutical companies with a fast turnaround time. The private company is based in Coventry, UK. The British company has a large portfolio of clients, ranging from small start-ups to multinational pharmaceutical companies, which validates their quality, reliability, speed, and discretion. The company was founded by Kevin Lee. NeuroSolutions was acquired by NeuroSolutions /Private Group/ from OncoSil Medical Ltd. on August 11, 2010 for $0.72 million. | Miscellaneous Commercial Services | Chairman | |
ONCOSIL MEDICAL LIMITED | Medical Specialties | Chairman | |
University of Surrey | College/University | Undergraduate Degree | |
University of Basel | College/University | Corporate Officer/Principal | |
Polpharma Biologics Utrecht BV
Polpharma Biologics Utrecht BV Miscellaneous Commercial ServicesCommercial Services Polpharma Biologics Utrecht BV operates as a biopharmaceutical research and development company. It specializes in the development of monoclonal antibodies generation, cell line, upstream process, downstream process, analytical, and bioassay development services. The company is headquartered in Utrecht, the Netherlands. | Miscellaneous Commercial Services | Chairman | |
BIOSEEK PLC | Miscellaneous Commercial Services | Director/Board Member | |
Tocris Bioscience
Tocris Bioscience Chemicals: SpecialtyProcess Industries Part of Tocris Bioscience Management, Tocris Bioscience supplies all types of chemicals. The company is based in Bristol, UK. Tocris Bioscience was acquired by Tocris Bioscience Management on January 11, 2007 for $39.86 million. | Chemicals: Specialty | Corporate Officer/Principal | |
DEEPMATTER GROUP PLC | Packaged Software | Director/Board Member | |
Ampika Ltd.
Ampika Ltd. Drugstore ChainsRetail Trade Ampika Ltd. discovers and develops drugs. It develops consumer products and prescription drugs from plant-based compounds. Its products includes cardiovascular protection, anti-infectives, diabetes, oncology, dermatological conditions and neurological. The company was founded by Francoise Barbira Freedman, Margaret Adey, Paul Rodgers and Jonathan Mark Treherne in May 2003 and is headquartered in Cambridge, the United Kingdom. | Drugstore Chains | Founder | |
Acidophil LLC
Acidophil LLC Medical/Nursing ServicesHealth Services Acidophil LLC develops biotechnologies and products in the field of applied genetics and molecular engineering. It uses synthetic biology and/or synthetic chemistry to apply the lessons of evolution to the discovery and development of novel bioactive compounds and related production processes for a variety of market sectors. The company was founded by Sydney Brenner and Philip Goelet and is headquartered in Lutherville, MD. | Medical/Nursing Services | Director/Board Member | |
Avilex Pharma ApS
Avilex Pharma ApS Pharmaceuticals: MajorHealth Technology Avilex Pharma ApS develops and produces drugs to treat brain damage with the uses of dimeric ligands. It also develops novel inhibitors to target a range of unmet medical needs. The firm uses dimeric ligands that targets intracellular with unprecedented potency. The company was founded by Kristian Strømgaard and Anders Bach on December 27, 2012 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Cyclofluidic Ltd.
Cyclofluidic Ltd. Miscellaneous Commercial ServicesCommercial Services Cyclofluidic Ltd. is a British private company. The firm operates proprietary microfluidic drug discovery platform. | Miscellaneous Commercial Services | Chairman | |
Oxford Biotrans Ltd.
Oxford Biotrans Ltd. Chemicals: Major DiversifiedProcess Industries Oxford Biotrans Ltd. develops and commercializes enzymatic process technologies that produce chemical compounds. The firm produces chemicals using ‘green’ biotransformation technology to starting materials into initial focus is on flavors and fragrances using its proprietary understanding of P450 enzyme catalyst technology. The company was founded by Luet Lok Wong in 2013 and is headquartered in Milton Park, the United Kingdom. | Chemicals: Major Diversified | Director/Board Member | |
Talisman Therapeutics Ltd.
Talisman Therapeutics Ltd. BiotechnologyHealth Technology Talisman Therapeutics Ltd. is a human stem cell research and development company. The firm is committed for revolutionizing the discovery of treatments for Alzheimer’s disease. The company is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chairman | |
NuVision Biotherapies Ltd.
NuVision Biotherapies Ltd. Pharmaceuticals: MajorHealth Technology NuVision Biotherapies Ltd. commercializes biotherapies for treating ‘front of the eye’ disease and trauma. It offers Omnigen, an ‘off the shelf’, transportable biological matrix that can be used as an effective wound dressing for a range of indications including ocular surface indications. The firm also offers Tereo, a process that gently preserves the tissue such that it is stored in a dry state. The company was founded by Andrew Hopkinson in July 2014 and is headquartered in Nottingham, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Cellesce Ltd.
Cellesce Ltd. BiotechnologyHealth Technology Cellesce Ltd. develops bioprocessing technology for organoids. Its products include colorectal cancer organoids and organoids of other human organs. The company was founded in 2013 and is headquartered in Cardiff, the United Kingdom. | Biotechnology | Director/Board Member | |
Pharmasum Therapeutics AS
Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | Biotechnology | Director/Board Member | |
NanoView Biosciences, Inc.
NanoView Biosciences, Inc. Medical SpecialtiesHealth Technology NanoView Biosciences, Inc. engages in research and development of non technology. It develops ExoView platform that provides critical information that will assist in the translation of extracellular vesicle research into the clinical and therapeutic environment. The company was founded by David Freedman and George G. Daaboul and is headquartered in Boston, MA. | Medical Specialties | Director/Board Member | |
Rosa Biotech Ltd.
Rosa Biotech Ltd. Packaged SoftwareTechnology Services Rosa Biotech Ltd. is a British company that is redefining biosensing. The company is based in Bristol, UK. The company is focused on addressing intractable challenges in early disease diagnosis and industrial biotechnology. The company was founded in 2019. Mark Street-Docherty has been the CEO of the company since 2022. | Packaged Software | Director/Board Member | |
Manor Road Lettings Ltd. | Director/Board Member | ||
Monument Therapeutics Ltd.
Monument Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Monument Therapeutics Ltd. is a British UK-based biotechnology company that focuses on bringing precision medicine to neuroscience drug development. The company is based in Bottisham, UK, and was founded in 2019. The company was formed as a spin-out from Cognition and has a mission to use precision medicine to develop therapeutic products for patients with substantial central nervous system indications and significant unmet medical needs. Monument Tx has a well-balanced pipeline that includes two lead programs, and proprietary biomarkers developed by the team allow for precise selection of patients most likely to benefit from treatment. The therapeutic products under development are novel formulations utilizing well-characterized technology. Jenny Barnett has been the CEO of the company since 2019. | Pharmaceuticals: Major | Chairman | |
Spliceor Ltd.
Spliceor Ltd. BiotechnologyHealth Technology Spliceor Ltd. is a British company founded in 2020 that specializes in gene therapies for aggressive cancers. The company is based in Cambridge, UK. The company's website is currently under construction, but more details are expected to follow. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
Verenigd Koninkrijk | 25 |
Verenigde Staten | 12 |
Denemarken | 3 |
Frankrijk | 2 |
Australië | 2 |
Sectoraal
Health Technology | 20 |
Consumer Services | 10 |
Commercial Services | 8 |
Process Industries | 3 |
Technology Services | 3 |
Operationeel
Director/Board Member | 22 |
Chairman | 12 |
Corporate Officer/Principal | 7 |
Founder | 5 |
President | 3 |
Sterkste connecties
Insiders | |
---|---|
Jonathan Treherne | 24 |
Ian W. Ratcliffe | 11 |
Laurence Ede | 7 |
Kate Rowley | 4 |
Jason Mundin | 1 |
- Beurs
- Insiders
- Dario Alessi
- Bedrijfsconnecties